David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Clorox
CLX
$12.7B
| $1.32M | ﹤0.01% |
10,028
-190,603
| -95% | -$25.6M |
|
|
VIAB
2277
CALL
DELISTED
Viacom Inc. Class B
VIAB
| $1.32M | ﹤0.01% |
47,500
+7,100
| +18% | +$219K |
|
2278
Resources Connection
RGP
$147M
| $1.32M | ﹤0.01% |
95,050
+26,585
| +39% | +$347K |
|
2279
Hancock Whitney
HWC
$5.99B
| $1.32M | ﹤0.01% |
27,208
+11,303
| +71% | +$518K |
|
|
SFS
2280
DELISTED
Smart & Final Stores, Inc.
SFS
| $1.32M | ﹤0.01% |
167,580
+118,232
| +240% | +$910K |
|
2281
VSE Corp
VSEC
$6.11B
| $1.31M | ﹤0.01% |
23,118
+3,206
| +16% | +$160K |
|
|
HMHC
2282
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $1.31M | ﹤0.01% |
108,899
-45,432
| -29% | -$511K |
|
2283
PUT
Ares Capital
ARCC
$14.3B
| $1.31M | ﹤0.01% |
80,000
+39,800
| +99% | +$644K |
|
|
INVX
2284
Innovex International
INVX
$2.01B
| $1.31M | ﹤0.01% |
29,580
+13,542
| +84% | +$589K |
|
|
CHUY
2285
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $1.31M | ﹤0.01% |
62,046
+52,904
| +579% | +$1.12M |
|
2286
RB Global
RBA
$15.7B
| $1.3M | ﹤0.01% |
41,232
+28,881
| +234% | +$837K |
|
2287
Royal Bank of Canada
RY
$284B
| $1.3M | ﹤0.01% |
16,816
-49,527
| -75% | -$3.7M |
|
2288
CALL
Royal Gold
RGLD
$22.7B
| $1.3M | ﹤0.01% |
15,100
+5,100
| +51% | +$442K |
|
2289
Hanmi Financial
HAFC
$918M
| $1.3M | ﹤0.01% |
41,894
-19,973
| -32% | -$559K |
|
|
ZOES
2290
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $1.29M | ﹤0.01% |
102,505
+27,648
| +37% | +$337K |
|
2291
Cerus
CERS
$548M
| $1.29M | ﹤0.01% |
474,198
+334,424
| +239% | +$820K |
|
|
PDM
2292
Piedmont Realty Trust
PDM
$1.24B
| $1.29M | ﹤0.01% |
64,074
+50,740
| +381% | +$1.03M |
|
|
PCBK
2293
DELISTED
Pacific Continental Corp
PCBK
| $1.29M | ﹤0.01% |
47,915
+30,888
| +181% | +$764K |
|
|
DFS
2294
PUT
DELISTED
Discover Financial Services
DFS
| $1.29M | ﹤0.01% |
20,000
| – | – |
|
2295
Tapestry
TPR
$25.9B
| $1.29M | ﹤0.01% |
+32,010
| New | +$1.41M |
|
|
GIFI
2296
DELISTED
Gulf Island Fabrication
GIFI
| $1.29M | ﹤0.01% |
101,392
-20,056
| -17% | -$230K |
|
2297
Monster Beverage
MNST
$95.5B
| $1.29M | ﹤0.01% |
+93,244
| New | +$1.26M |
|
|
BBBY
2298
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
| $1.29M | ﹤0.01% |
54,800
+4,800
| +10% | +$134K |
|
|
KYNB
2299
Kyntra Bio
KYNB
$32.8M
| $1.28M | ﹤0.01% |
954
-104
| -10% | -$110K |
|
2300
CALL
SBA Communications
SBAC
$19.9B
| $1.28M | ﹤0.01% |
+8,900
| New | +$1.27M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.